Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
REVISED GMP REGULATION WILL EXEMPT MOST CLASS I DEVICES FROM DESIGN CONTROLS, FDA'S JOHNSON SAYS; ALL CLASS II PRODUCTS WILL FACE DESIGN REQUIREMENTS
Sep 27 1993
More from Archive
More from Medtech Insight